Mumbai-based healthcare company Glenmark Pharma started off financial year 2016-17 on a strong note with earnings beating analysts' expectations on Friday. Profit jumped 24 percent to Rs 226.8 crore on yearly basis. Revenue grew by 18 percent to Rs 1,943 crore YoY. Profit was estimated at Rs 194 crore on revenue of Rs 1,885.7 crore for the quarter, according to average of estimates of analysts polled by CNBC-TV18.
Good fundamental updates i learned here. always analyze market technically and fundamentally and then decide whether to invest in its stock or not. For best recommendations on stock market follow epic research.
ReplyDelete